Breaks Categories: News

WednesdayJul 30, 2025 12:56 pm

NetworkNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Selected for U.S. Army Futures Command Warfighting Experiment 

Safe Pro Group (NASDAQ: SPAI), a leader in artificial intelligence-powered defense and security solutions, announced it has been chosen to participate in the U.S. Army Futures Command’s Concept Focused Warfighting Experiment Maneuver (CFWE-M) 2026 at Fort Benning, Georgia, in March and April 2026. The event is the Army’s primary venue for small unit modernization, enabling collaboration among Cross Functional Teams, Centers of Excellence, the science and technology community and industry. Safe Pro will demonstrate its patented SpotlightAI(TM) drone-based imagery analysis platform, capable of detecting and identifying more than 150 types of landmines and unexploded ordnance in fractions of a second…

Continue Reading

WednesdayJul 30, 2025 12:40 pm

NetworkNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Highlights Lando Norris and Quadrant Speedway Launch at Belgian Grand Prix

SEGG Media (NASDAQ: SEGG, LTRYW), a technology company at the intersection of sports, entertainment and gaming, spotlighted McLaren driver and Quadrant founder Lando Norris at the Belgian Grand Prix, where he secured pole position and a podium finish. Ahead of the race, Norris unveiled the upcoming Quadrant Speedway collection, set for release on July 31, marking the first major drop since Veloce Media Group’s acquisition of Quadrant. The event underscored SEGG Media’s strategic investment in Veloce, which drives 750 million monthly views and 55 million subscribers across its network. SEGG Media Chairman and CEO Matthew McGahan said Norris’ visibility and…

Continue Reading

WednesdayJul 30, 2025 9:35 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Launches Enterprise Data Monetization With IBM watsonx.ai-Powered Agents

Datavault AI (NASDAQ: DVLT), a platinum partner in IBM Partner Plus, announced the expanded commercialization of its flagship AI agents, DataScore and DataValue, now embedded with IBM watsonx.ai. Designed to turn enterprise data into financial assets, the tools aim to streamline modeling, risk assessment and pricing strategies across on-premises, cloud and hybrid environments. With generative AI projected to add as much as $4.4 trillion annually to major business sectors, the integration positions Datavault AI to help companies tap into the next wave of AI-driven automation and enterprise data monetization. The partnership underscores IBM’s strategy to accelerate AI adoption in industries…

Continue Reading

WednesdayJul 30, 2025 9:20 am

NetworkNewsBreaks – AI Maverick Intel, Inc. (OTCID: BINP) Engages IBN to Lead Corporate Communications Strategy

AI Maverick Intel (OTC PINK: BINP), a technology-forward company focused on transforming business customer acquisition through artificial intelligence, selected IBN to manage its corporate communications efforts. AI Maverick Intel’s proprietary platform delivers human-like, AI-powered prospecting with adaptive engagement across sectors including healthcare, biotech, insurance and transportation. Following its May 2025 rebrand and platform acquisition, the company launched an enhanced version in July designed to handle transactional and consultative sales engagements with context-aware messaging and autonomous dialogues. The platform aims to shorten deal cycles and reduce acquisition costs while positioning AI Maverick to capture growth in the AI-in-marketing sector. IBN will…

Continue Reading

WednesdayJul 30, 2025 9:10 am

NetworkNewsBreaks – BluSky AI Inc. (OTC: BSAI) Signs LOI to Acquire 15 Acres in Arizona for Modular AI Expansion

BluSky AI (OTC: BSAI), a leading innovator in modular AI infrastructure, signed a Letter of Intent (LOI) to purchase approximately 15 acres of industrial land in Camp Verde, Arizona. The site includes existing electrical infrastructure capable of supporting 1.75 megawatts (MW), with plans to expand to 3.75 MW to meet growing demand. CEO Trent D’Ambrosio said the acquisition reflects BluSky AI’s mission to deliver scalable, energy-efficient compute solutions across the Southwest, positioning its SkyMod technology closer to the edge. The transaction is expected to close later this year with groundbreaking planned for mid-2026. To view the full press release, visit…

Continue Reading

WednesdayJul 30, 2025 9:00 am

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Aug. 13 Call to Discuss Q2 Results and Provide Business Updates

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care with personalized insights, will hold a conference call Aug. 13, 2025, at 4:30 p.m. Eastern to discuss second-quarter results for the period ended June 30, 2025. The company will also provide updates on regulatory initiatives, commercial-readiness activities and anticipated milestones. CEO Robert Eno and CFO Timothy Cruickshank will host the call, followed by a question-and-answer session. To view the full press release, visit https://nnw.fm/0KtNc About HeartBeam Inc. HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The…

Continue Reading

TuesdayJul 29, 2025 12:58 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Publishes Peer-Reviewed Data Supporting PC111 as Potential Disease Modifier 

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company developing inflammation and immunology biological products and providing boutique CDMO services, announced the publication of a peer-reviewed article in the Journal of Dermatological Treatment confirming the disease-modifying potential of PC111, a first-in-class human anti-Fas Ligand monoclonal antibody. The study demonstrated PC111’s ability to prevent blister formation in humanized models of pemphigus by targeting soluble Fas Ligand, offering a differentiated, non-immunosuppressive approach. Data also highlighted potential use in SJS/TEN, a life-threatening dermatological condition. CEO Amir Reichman said the findings reinforce PC111’s potential to transform treatment for these high unmet-need indications and deliver meaningful value…

Continue Reading

TuesdayJul 29, 2025 12:50 pm

NetworkNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights IzoView Breast CT Advantages Over Existing Imaging Technologies

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing imaging-based products for breast cancer detection and treatment, released an educational overview comparing its IzoView Breast CT Imaging System to current breast imaging technologies. IzoView offers true 3D, ultra-high-resolution imaging without breast compression and is designed to bridge the gap between digital breast tomosynthesis and MRI. Developed under a global license from UC Davis, IzoView delivers 100x greater spatial resolution than MRI at a lower cost and with shorter scan times, aiming to improve screening, diagnosis, and treatment planning, particularly in women with dense breast tissue. To view…

Continue Reading

TuesdayJul 29, 2025 12:13 pm

NetworkNewsBreaks – Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) Spotlighted by Bloomberg for Upcoming Launch of Louisiana Rare Earths Plant

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) has been featured in a Bloomberg article for its role in helping reshape North America’s critical minerals infrastructure with its landmark facility in Louisiana set to begin production in May 2026. Backed by $18.4 million in U.S. Department of Defense funding and located within a designated foreign-trade zone, the $80 million rare earths plant will handle materials used in defense, electric vehicles, and consumer electronics. CEO Pat Ryan described the site as a strategic hub that enables global feedstock inputs and tariff-free exports to partners in Japan and beyond. The article also…

Continue Reading

TuesdayJul 29, 2025 11:54 am

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) CEO to Join Fireside Chat at BTIG Virtual Biotechnology Conference

NRx Pharmaceuticals (NASDAQ: NRXP), announced that CEO and Chairman Prof. Jonathan Javitt, MD, MPH will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on July 29–30, 2025. The discussion, scheduled for 8:00 a.m. EDT on July 30, will feature Prof. Samuel Wilkinson, MD, of Yale School of Medicine, and BTIG Research Analyst Dr. Thomas Shrader. The session will focus on neuroplasticity in treating CNS disorders, including the use of ketamine and other neuroplastic and psychedelic drugs for depression, suicidality, and PTSD. To view the full press release, visit https://nnw.fm/Kdcs0 About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals is a…

Continue Reading